GlycoMimetics Long Term Debt 1970-1969 | GLYC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GlycoMimetics long term debt from 1970 to 1969. Long term debt can be defined as the sum of all long term debt fields.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GlycoMimetics long term debt from 1970 to 1969. Long term debt can be defined as the sum of all long term debt fields.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$75.3B
Zoetis (ZTS)	$68.1B
Takeda Pharmaceutical (TAK)	$46.9B
Daiichi Sankyo, - (DSNKY)	$43.1B
BeOne Medicines - (ONC)	$29.6B
Sandoz Group AG (SDZNY)	$25B
Summit Therapeutics (SMMT)	$18.1B
Merck (MKKGY)	$16.5B
Shionogi (SGIOY)	$14.2B
United Therapeutics (UTHR)	$13.2B
Neurocrine Biosciences (NBIX)	$13B
Orion OYJ (ORINY)	$11B
IPSEN (IPSEY)	$10.2B
Stevanato Group S.p.A (STVN)	$7.8B
Corcept Therapeutics (CORT)	$7.6B
Madrigal Pharmaceuticals (MDGL)	$6.9B
Grifols, S.A (GRFS)	$6.7B
Ionis Pharmaceuticals (IONS)	$6.7B
Hikma Pharmaceuticals Plc (HKMPF)	$6.2B
Ono Pharmaceutical (OPHLF)	$5.3B
Soleno Therapeutics (SLNO)	$4.2B
Hypermarcas (HYPMY)	$3.2B
Crinetics Pharmaceuticals (CRNX)	$3B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.6B
Catalyst Pharmaceuticals (CPRX)	$2.6B
NewAmsterdam Pharma (NAMS)	$2.4B
Centessa Pharmaceuticals (CNTA)	$2B
BioCryst Pharmaceuticals (BCRX)	$1.8B
Ocular Therapeutix (OCUL)	$1.8B
ARS Pharmaceuticals (SPRY)	$1.7B